Fresenius SE & Co. (FSNUY)
(Delayed Data from OTC)
$12.02 USD
+0.01 (0.08%)
Updated Aug 5, 2025 11:20 AM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FSNUY 12.02 +0.01(0.08%)
Will FSNUY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FSNUY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FSNUY
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Is Fresenius SE & Co. (FSNUY) Stock Undervalued Right Now?
FSNUY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for FSNUY
Tweedy, Browne Mutual Funds Q2 2025 Commentary
Fresenius Medical in pact with Coordination of National Institutes in Mexico
Fresenius Medical in-pact with Coordination of National Institutes in Mexico
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from UBS
UBS Remains a Buy on Fresenius SE & Co. KGaA (0OO9)